COVAXIN intranasal booster dose trials will be conducted at 9 different sites that includes AIIMS Delhi.
Drugs Controller General of India (DCGI) gives permission to @BharatBiotech for intranasal booster dose trials.#CovidVaccination pic.twitter.com/pP9QRzVRaV— DD News (@DDNewslive) January 28, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


